Treatment of postpartum depression, part 1: A critical review of biological interventions

被引:51
作者
Dennis, CLE [1 ]
Stewart, DE [1 ]
机构
[1] Univ Toronto, Fac Nursing, Toronto, ON M5S 3H4, Canada
关键词
D O I
10.4088/JCP.v65n0914
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: While postpartum depression is a major health issue for many women from diverse cultures, this affective condition often remains undiagnosed and untreated. The objective of this article is to critically review the literature to determine the current state of scientific knowledge related to the treatment of postpartum depression from a biological perspective. Method: Databases searched for this review included MEDLINE, PubMed, CINAHL, PsycINFO, EMBASE, ProQuest, the Cochrane Library, and the WHO Reproductive Health Library from 1966 to 2003. The search terms used were postpartum/postnatal depression and randomized controlled/clinical trials in various combinations. Published peer-reviewed articles in English from 1990 to 2003 were chosen for review, although select earlier studies were also included based on good methodological quality and/or the absence of more recent work. The criteria used to evaluate the interventions were based on the standardized methodology developed by the U.S. Preventive Services Task Force and the Canadian Task Force on Preventive Health Care. Results: Nine studies that met study criteria were examined. The interventions studied included antidepressant medication, estrogen therapy, critically timed sleep deprivation, and bright light therapy. Although some of these interventions have been better studied for depression unrelated to childbirth, methodological limitations render their efficacy equivocal for postpartum depression with limited strong evidence available to guide practice or policy recommendations. Conclusions: Despite the recent upsurge of interest in this area, many questions remain unanswered, resulting in diverse research implications. In view of the lack of randomized controlled trials, psychiatrists who are experts in the treatment of postpartum mood disorders have developed consensus guidelines. These guidelines will require regular updating as better and stronger evidence emerges.
引用
收藏
页码:1242 / 1251
页数:10
相关论文
共 137 条
[71]   POSSIBLE ASSOCIATION BETWEEN FLUOXETINE HYDROCHLORIDE AND COLIC IN AN INFANT [J].
LESTER, BM ;
CUCCA, J ;
ANDREOZZI, L ;
FLANAGAN, P ;
OH, W .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1993, 32 (06) :1253-1255
[72]  
LINDBERG C, 1984, EUR J RESPIR DIS, V65, P87
[73]   ELECTROCONVULSIVE-THERAPY IN A TWIN PREGNANCY - A CASE-REPORT [J].
LIVINGSTON, JC ;
JOHNSTONE, WM ;
HADI, HA .
AMERICAN JOURNAL OF PERINATOLOGY, 1994, 11 (02) :116-118
[74]  
Llett KF, 1998, BRIT J CLIN PHARMACO, V45, P459, DOI 10.1046/j.1365-2125.1998.00710.x
[75]  
Llewellyn A, 1998, J CLIN PSYCHIAT, V59, P41
[76]   TERBUTALINE EXCRETION INTO BREAST-MILK [J].
LONNERHOLM, G ;
LINDSTROM, B .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) :729-730
[77]   Treatment guidelines for depression in pregnancy [J].
Marcus, SM ;
Barry, KL ;
Flynn, HA ;
Tandon, R ;
Greden, JF .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2001, 72 (01) :61-70
[78]   MILK CONCENTRATIONS OF FLUPENTIXOL, NORTRIPTYLINE AND ZUCLOPENTHIXOL AND BETWEEN-BREAST DIFFERENCES IN 2 PATIENTS [J].
MATHESON, I ;
SKJAERAASEN, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (02) :217-220
[79]   CLINICAL PHARMACOKINETICS OF THE MONOAMINE OXIDASE-A INHIBITOR MOCLOBEMIDE [J].
MAYERSOHN, M ;
GUENTERT, TW .
CLINICAL PHARMACOKINETICS, 1995, 29 (05) :292-332
[80]   THE EFFECTS OF BENZODIAZEPINE USE DURING PREGNANCY AND LACTATION [J].
MCELHATTON, PR .
REPRODUCTIVE TOXICOLOGY, 1994, 8 (06) :461-475